Celesio signs new revolver
German pharmaceutical distributer Celesio has renewed its revolving loan facility, replacing a €600m line due to expire this year with a new €500m credit for use until 2018.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
